Curtiland Deville Jr. MD
Sarcoma, Urologic Cancer
Associate Professor, Radiation Oncology, Johns Hopkins University
Join to View Full Profile
5255 Loughboro Road NorthwestWashington, DC 20016
Phone+1 202-537-4788
Fax+1 202-243-5271
Dr. Deville is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a radiation oncologist with Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, medical director of the Johns Hopkins Proton Therapy Center at Sibley and associate professor of radiation oncology and molecular radiation sciences with the Johns Hopkins School of Medicine. My areas of clinical practice are genitourinary malignancies, including prostate cancer, and soft tissue sarcomas. I have a special interest in effective treatment of prostate cancer with proton therapy and serve as a site primary investigator for the Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer (COMPPARE).
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 2006 - 2010
MedStar Health Georgetown University/Harbor HospitalInternship, Transitional Year, 2005 - 2006
The Warren Alpert Medical School of Brown UniversityClass of 2005
Certifications & Licensure
FL State Medical License 2010 - 2027
DC State Medical License 2014 - 2026
MD State Medical License 2014 - 2026
PA State Medical License 2007 - 2026
VA State Medical License 2022 - 2026
NJ State Medical License 2010 - 2015
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
- Proton Beam Radiation Therapy in Treating Patients With Retroperitoneal Sarcoma Start of enrollment: 2009 Nov 01
- Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
- Proton Radiotherapy for Extremity Soft Tissue Sarcoma Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- Particle Therapy Co-Operative Group Consensus Statement on Reirradiation With Proton Therapy for Prostate Cancer.Shaakir Hasan, Xinglei Shen, Huan Giap, Sagar Patel, Christian Hyde
International Journal of Particle Therapy. 2026-06-01 - Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Pha...Sean M McBride, Daniel E Spratt, Marisa Kollmeier, Wassim Abida, Han Xiao
Clinical Cancer Research. 2026-05-01 - A Prospective Validation of the Decipher Genomic Classifier in Men With Early Localized Prostate Cancer: The VANDAAM Study.Kosj Yamoah, Purvish Trivedi, Shivanshu Awasthi, G Daniel Grass, Javier Torres-Roca
Journal of the National Comprehensive Cancer Network. 2025-12-17
Journal Articles
- Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the Internationa...Michael J Zelefsky, Matthew R Cooperberg, Brian J Davis, Eric M Horwitz, Martha K Terris, Christopher L Amling, Christopher J Kane, Curtiland Deville, Theodore L Dewee..., JAMA Oncology
Authored Content
- UPDATES FROM ASTRO’S COMMITTEE ON HEALTH EQUITY, DIVERSITY AND INCLUSION (CHEDI)7/24/2018
- Biochemical Results, Toxicity, and Quality of Life After Delivery of Dose-Escalated Image-Guided Proton Therapy for Prostate Cancer5/3/2016
Press Mentions
‘Man Van’ Diagnoses Clinically Significant but Nonmetastatic Prostate CancersFebruary 14th, 2025- IMRT vs Proton Therapy for Early Prostate Cancer?October 1st, 2024
- Dr. Howard Sandler Voted President-Elect of the American Society for Radiation Oncology (ASTRO)July 13th, 2022
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Other Languages
- Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
